Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson’s Disease

Parkinson’s disease (PD) is characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Restoration of nigrostriatal dopamine neurons has been proposed as a potential therapeutic strategy for PD. Because currently used PD therapeutics only help relieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Pariyar, Ramesh, Bastola, Tonking, Lee, Dae Ho, Seo, Jungwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877991/
https://www.ncbi.nlm.nih.gov/pubmed/35216503
http://dx.doi.org/10.3390/ijms23042388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877991/
https://www.ncbi.nlm.nih.gov/pubmed/35216503
http://dx.doi.org/10.3390/ijms23042388

Ejemplares similares